Teva Pharmaceutical Industries Limited Stock Price and Value Analysis

Should you buy Teva Pharmaceutical Industries Limited stock? (NYSE:TEVA). Let's see how it does in our automated value investing analysis system.

AdvantagesDisadvantagesNeutral
  • This stock is on sale.
  • This company has wild ups and downs.
  • This company is making money at a modest rate.
  • This company is less known than others.
  • This company pays no dividend.

Inside the TEVA Numbers

TEVA Price
(Teva Pharmaceutical Industries Limited stock price per share)
$36.93
[?]
TEVA Fair Price
(based on intrinsic value)
$50.62
[?]
TEVA Safety Price (based on a variable margin of safety) $30.37
[?]
PE Ratio versus Sector 207% higher than other Healthcare stocks
[?]
PE Ratio versus Industry 1186% higher than other Drug Manufacturers - General stocks
[?]
Cash Yield 13.97%
[?]
Free Cash Flow Jitter 155%

Recent Insider Activity

Open-market buys and sells reported by Teva Pharmaceutical Industries Limited's officers, directors, and 10% owners on SEC Form 4. Routine transactions (tax withholding, option exercises, and stock grants) are excluded -- these are discretionary trades only.

Date Insider Type Shares Price
2026-08-05T00:00:00 Zaks Tal Zvi Sell 17 $34.87
2026-08-03T00:00:00 Hughes Eric A (See "Remarks") Sell 25,578 $34.88
2026-08-03T00:00:00 Jover Placid (See "Remarks") Sell 12,827 $34.88
2026-06-18T00:00:00 Shields Matthew (EVP, Global Operations) Sell 9,989 $32.19
2026-06-11T00:00:00 Kalif Eliyahu Sharon (EVP, Chief Financial Officer) Sell 106,563 $34.10
2026-06-05T00:00:00 Francis Richard D (President and CEO) Sell 6,153 $34.35
2026-06-03T00:00:00 Shields Matthew (EVP, Global Operations) Sell 16,195 $32.87
2026-05-14T00:00:00 Kalif Eliyahu Sharon (EVP, Chief Financial Officer) Sell 153,251 $35.61
2026-05-14T00:00:00 Lippman Evan (EVP, Business Development) Sell 35,912 $35.58
2026-05-14T00:00:00 Lippman Evan (EVP, Business Development) Sell 5,746 $35.58

This stock has short interest! This means that people have shorted it.

Why does that matter? They've made a bet that price will decrease from where they bought it. Maybe there are financial problems, or maybe there's a value play.

As of the latest analysis, there are 34,320,980 shares shorted. With 1,087,069,758 shares available for purchase and an average trading volume over the past 10 trading days of 5,586,210, it would take at least 6.144 days for all of the short holders to cover their shorts.

Is Teva Pharmaceutical Industries Limited Stock on Sale?

We believe that Teva Pharmaceutical Industries Limited may be worth examining further. It's making money, which is a very positive sign. Is it on sale?

Teva Pharmaceutical Industries Limited looks like a price in the fair value range. Based on our analysis—if the company keeps making money the way it has been—you could be looking at a good stock. See Before You Buy for your next steps.

Should You Buy TEVA Stock?

Does Teva Pharmaceutical Industries Limited have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.